A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency

NCT01909479 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
202
Enrollment
INDUSTRY
Sponsor class

Stopped Main Study was completed. LT-OLE was discontinued as sufficient safety data has been generated.

Conditions

Interventions

Sponsor

OPKO Health, Inc.